Inactive

NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Deuterium oxide 70% purchase (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart... NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Deuterium oxide 70% purchase (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95024Q00255 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), NIDA Office of Acquisitions – National Institute on Aging (NIA) Section, on behalf of the NIA intends to negotiate and award a purchase order without providing for full and open competition (Including brand-name) to Cambridge Isotope Laboratories, Inc., 3 Highwood Drive, Tewksbury, MA, 01876, USA, for the purchase of Deuterium Oxide 70%. The anticipated award date is 4/10/2024. This acquisition is non-competive. This is due to the fact that Cambridge Isotope Laboratories has been providing all of the Deuterium oxide 70% for use this study. The NIA Clinical unit must continue to use isotopes from Cambridge Isotopes to maintain scientific integrity. To use isotopes from another company would invalidate all research data that has been collected thus far. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2024-03, dated 2/24/2024. (iv) The associated NAICS code 325413 and the small business size standard is 1250 employees. This requirement has no set-aside restrictions. (v) Project requirements: The Contractor shall provide NIA with the following: Deuterium oxide (D, 70%) microbiological tested. Catalog Number DLM-2259-70-1L. Quantity 95. Shipping and Handling costs shall be included in the quote. (vi) Delivery Location: The National Institute on Aging (NIA) 35 Convent Drive Bethesda, MD 20892 (vii) The provision at FAR clause 52.212-1, Instructions to Offerors – Commercial Products and Commercial Services, applies to this acquisition. (viii) The provision at FAR clause 52.212-2, Evaluation – Commercial Products and Commercial Services, applies to this acquisition. The award resulting from this solicitation will be made to the responsible offeror whose proposal is most advantageous to the Government, Technical Capability, Past Peformance and other factors considered. (b) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (ix) Offerors are to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services, with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. (x) The FAR clause at 52.212-4, Contract Terms and Conditions – Commercial Products and Commercial Services, applies to this acquisition. The following FAR provisions or clauses are incorporated by reference: 52.204-7, System for Award Management (Oct 2018) 52.204-13, System for Award Management Maintenance (Oct 2018) 52.204-16, Commercial and Entity Code Reporting (Aug 2020) 52.204-18, Commercial and Entity Code Maintenance (Aug 2020) 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services of Equipment (Nov 2021) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015). 52.212-4(g), Invoice, is supplemented by the NIH Invoice and Payment Instructions (3/2023). (xi) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders–Commercial Products and Commercial Services (Feb 2024), applies to this acquisition (xii) The offeror must complete and return FAR 52.204-24 and FAR 52.204-26 with its offer. (xiii) Responses to this solicitation must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. In addition the Unique Entity Identifier (UEI), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.” All responses must be received by May 1, 2024, 9:00 am, Eastern Standard Time and reference number 75N95024Q00255. Responses shall be submitted electronically to Kevin Alvarez, Contracting Officer, kevin.alvarez@nih.gov. Fax responses will not be accepted. (xiv) The name of the individual to contact for information regarding the solicitation: Kevin Alvarez, Contracting Officer, kevin.alvarez@nih.gov. Attachments: FAR 52.212-5 Copy of FAR 52.204-24, to be completed and submitted by offeror Copy of FAR 52.204-26, to be completed and submitted by offeror Invoice and payment provisions